Metropolitan Life Insurance Company (MetLife)’s PMV Pharmaceuticals PMVP Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,183	Closed	-$13.4K	–	2378
2023 Q3	$13.4K	Hold	2,183	–	–	﹤0.01%	2083
2023 Q2	$13.7K	Buy	+2,183	New	+$11.4K	﹤0.01%	2131
2023 Q1	–	Sell	-2,387	Closed	-$20.8K	–	2428
2022 Q4	$20.8K	Hold	2,387	–	–	﹤0.01%	1989
2022 Q3	$28.4K	Hold	2,387	–	–	﹤0.01%	1822
2022 Q2	$34K	Buy	2,387 +470	+25%	+$6.84K	﹤0.01%	1741
2022 Q1	$39.9K	Sell	1,917 -6,207	-76%	-$109K	﹤0.01%	1724
2021 Q4	$188K	Hold	8,124	–	–	﹤0.01%	2072
2021 Q3	$242K	Buy	+8,124	New	+$259K	﹤0.01%	1932
2021 Q2	–	Sell	-4,359	Closed	-$143K	–	2837
2021 Q1	$143K	Hold	4,359	–	–	﹤0.01%	2237
2020 Q4	$268K	Buy	+4,359	New	+$171K	﹤0.01%	1741

Other funds holding PMVP

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s PMVP Position: Q4 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of PMV Pharmaceuticals (PMVP) in Q4 2023, closing a stake of 2,183 shares — an estimated $13.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PMVP in Q4 2020 and held it in 10 quarters. The position peaked at $268K in Q4 2020. 98 funds tracked by Wall St. Rank hold PMVP as of Q4 2023.

Metropolitan Life Insurance Company (MetLife) reported no remaining PMV Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 2,183 PMV Pharmaceuticals shares in Q4 2023, an estimated $13.4K.
Metropolitan Life Insurance Company (MetLife) first reported a position in PMV Pharmaceuticals in Q4 2020 and held it in 10 quarters.
Metropolitan Life Insurance Company (MetLife)'s PMV Pharmaceuticals position peaked at $268K in Q4 2020.
98 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.